{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:37:28Z","timestamp":1792784248471,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DA058664"],"award-info":[{"award-number":["R01DA058664"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1TR004789"],"award-info":[{"award-number":["UM1TR004789"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DA047347"],"award-info":[{"award-number":["R01 DA047347"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007500","name":"Bloomberg Philanthropies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007500","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/01sv5vd96","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000875","name":"The Pew Charitable Trusts","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000875","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/02xhk2825","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100015283","name":"Bloomberg Philanthropies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015283","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/01sv5vd96","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.josat.2026.210114","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:11:02Z","timestamp":1789503062000},"page":"210114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Increased buprenorphine prescribing following implementation of a low-barrier virtual prescriber network"],"prefix":"10.1016","volume":"191","author":[{"given":"Zoe","family":"Lindenfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialiang","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Crystal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.josat.2026.210114_bb0005","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/archinternmed.2010.541","article-title":"Collaborative care of opioid-addicted patients in primary care using buprenorphine: Five-year experience","volume":"171","author":"Alford","year":"2011","journal-title":"Archives of Internal Medicine"},{"issue":"1","key":"10.1016\/j.josat.2026.210114_bb0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.amepre.2024.09.013","article-title":"Utilization of buprenorphine for opioid use disorder after the practitioner waiver removal","volume":"68","author":"Ali","year":"2025","journal-title":"American Journal of Preventive Medicine"},{"key":"10.1016\/j.josat.2026.210114_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2024.104569","article-title":"Barriers and facilitators to implementing CareConnect: A telehealth, low-barrier buprenorphine bridge clinic in Philadelphia","volume":"133","author":"Aronowitz","year":"2024","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2026.210114_bb0020","author":"Bloomberg Philanthropies"},{"issue":"3","key":"10.1016\/j.josat.2026.210114_bb0025","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.2732","article-title":"Prison buprenorphine implementation and postrelease opioid use disorder outcomes","volume":"7","author":"Bovell-Ammon","year":"2024","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2026.210114_bb0030","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.josat.2026.210114_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.rcsop.2021.100029","article-title":"A systematic literature review of patient perspectives of barriers and facilitators to access, adherence, stigma, and persistence to treatment for substance use disorder","volume":"2","author":"Cernasev","year":"2021","journal-title":"Exploratory Research in Clinical and Social Pharmacy"},{"issue":"1","key":"10.1016\/j.josat.2026.210114_bb0040","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/ADM.0000000000000739","article-title":"Retention strategies for medications for opioid use disorder in adults: A rapid evidence review","volume":"15","author":"Chan","year":"2021","journal-title":"Journal of Addiction Medicine"},{"issue":"3","key":"10.1016\/j.josat.2026.210114_bb0045","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3122\/jabfm.2022.220303R3","article-title":"Integrating harm reduction into medical care: Lessons from three models","volume":"36","author":"Chang","year":"2023","journal-title":"The Journal of the American Board of Family Medicine"},{"issue":"16","key":"10.1016\/j.josat.2026.210114_bb0050","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1001\/jama.2023.1207","article-title":"Trends in buprenorphine initiation and retention in the United States, 2016\u20132022","volume":"329","author":"Chua","year":"2023","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.josat.2026.210114_bb0055","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1377\/hlthaff.2025.00343","article-title":"States with substantial increases in buprenorphine uptake did so with increased Medicaid prescribing, 2018\u201324","volume":"44","author":"Crystal","year":"2025","journal-title":"Health Affairs"},{"issue":"4","key":"10.1016\/j.josat.2026.210114_bb0060","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/ADM.0b013e31829727b2","article-title":"Prior buprenorphine experience is associated with office-based buprenorphine treatment outcomes","volume":"7","author":"Cunningham","year":"2013","journal-title":"Journal of Addiction Medicine"},{"issue":"6","key":"10.1016\/j.josat.2026.210114_bb0065","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1111\/1475-6773.12993","article-title":"Matching and regression to the mean in difference-in-differences analysis","volume":"53","author":"Daw","year":"2018","journal-title":"Health Services Research"},{"key":"10.1016\/j.josat.2026.210114_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2025.209703","article-title":"Integration of harm reduction principles and practices within specialty substance use treatment programs in New Jersey: A qualitative study of program leadership","volume":"174","author":"Ganetsky","year":"2025","journal-title":"Journal of Substance Use and Addiction Treatment"},{"key":"10.1016\/j.josat.2026.210114_bb0075","author":"Girado"},{"key":"10.1016\/j.josat.2026.210114_bb0080","doi-asserted-by":"crossref","first-page":"8371","DOI":"10.12659\/MSM.916719","article-title":"Increased levels of glycated hemoglobin A1c and iron deficiency anemia: A review","volume":"25","author":"Guo","year":"2019","journal-title":"Medical Science Monitor: International Medical Journal of Experimental and Clinical Research"},{"key":"10.1016\/j.josat.2026.210114_bb0085","first-page":"10","article-title":"Individuals dispensed buprenorphine in the United States before and after federal policy changes aimed at increasing access","author":"Guy","year":"2024","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"10.1016\/j.josat.2026.210114_bb0090","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.53771","article-title":"Emergency department access to buprenorphine for opioid use disorder","volume":"7","author":"Herring","year":"2024","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2026.210114_bb0095","author":"HUD"},{"issue":"2","key":"10.1016\/j.josat.2026.210114_bb0100","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/00220426231204841","article-title":"Trends and barriers of medication treatment for opioid use disorders: A systematic review and meta-analysis","volume":"55","author":"Hutchison","year":"2025","journal-title":"Journal of Drug Issues"},{"issue":"8","key":"10.1016\/j.josat.2026.210114_bb0105","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.2105\/AJPH.2015.302664","article-title":"National and state treatment need and capacity for opioid agonist medication-assisted treatment","volume":"105","author":"Jones","year":"2015","journal-title":"American Journal of Public Health"},{"issue":"11","key":"10.1016\/j.josat.2026.210114_bb0110","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jamapsychiatry.2020.1624","article-title":"Comparison of driving times to opioid treatment programs and pharmacies in the US","volume":"77","author":"Kleinman","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.josat.2026.210114_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2019.05.002","article-title":"Expanding low-threshold buprenorphine to justice-involved individuals through mobile treatment: Addressing a critical care gap","volume":"103","author":"Krawczyk","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2026.210114_bb0120","series-title":"Optimizing opioid settlement funds to save lives: Investing in equitable solutions","author":"Krawczyk","year":"2023"},{"key":"10.1016\/j.josat.2026.210114_bb0125","first-page":"6","article-title":"Office-based opioid treatment with buprenorphine (OBOT-B): Statewide implementation of the Massachusetts collaborative care model in community health centers","volume":"60","author":"LaBelle","year":"2016","journal-title":"Journal of Substance Abuse Treatment, Special Issue on Studies on the Implementation of Integrated Models of Alcohol, Tobacco, and\/or Drug Use Interventions into Medical Care"},{"key":"10.1016\/j.josat.2026.210114_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.109933","article-title":"Change in opioid and buprenorphine prescribers and prescriptions by specialty, 2016\u20132021","volume":"248","author":"Larochelle","year":"2023","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.josat.2026.210114_bb0135","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13722-025-00565-y","article-title":"Forging hospital and community partnerships to enable care coordination for opioid use disorder","volume":"20","author":"Lindenfeld","year":"2025","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.josat.2026.210114_bb0140","first-page":"1","article-title":"Exploring barriers and facilitators to integrating a harm reduction approach to substance use in three medical settings","author":"Lindenfeld","year":"2023","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.josat.2026.210114_bb0145","article-title":"Examining SAMHSA funding awards by category before impending budget reductions, 2018\u20132024","author":"Lindenfeld","year":"2024","journal-title":"Journal of Addiction Medicine"},{"issue":"2","key":"10.1016\/j.josat.2026.210114_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002207.pub4","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2014","author":"Mattick","year":"1996","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1016\/j.josat.2026.210114_bb0160","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13011-024-00631-9","article-title":"Overcoming barriers to traditional care delivery and pharmacy challenges: A qualitative study of buprenorphine, telehealth, and a digital therapeutic for opioid use disorder","volume":"20","author":"Monico","year":"2025","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"issue":"5","key":"10.1016\/j.josat.2026.210114_bb0165","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/ajad.12896","article-title":"Long-term retention in an outpatient behavioral health clinic with buprenorphine","volume":"28","author":"Montalvo","year":"2019","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.josat.2026.210114_bb0170","article-title":"The intertwined expansion of telehealth and buprenorphine access from a prescriber hub","volume":"152","author":"Moore","year":"2021","journal-title":"Preventive Medicine, Behavior Change, Health, and Health Disparities 2021: Rural Addiction and Health"},{"key":"10.1016\/j.josat.2026.210114_bb0175","author":"NJ Consumer Affairs"},{"key":"10.1016\/j.josat.2026.210114_bb0180","author":"NJ DOH"},{"issue":"3","key":"10.1016\/j.josat.2026.210114_bb0185","first-page":"207","article-title":"When a city isn\u2019t a city: Aggregating data from the picture of subsidized households to the municipal scale for research purposes","volume":"25","author":"Payne","year":"2023","journal-title":"Cityscape"},{"key":"10.1016\/j.josat.2026.210114_bb0190","series-title":"RealFix","author":"RealFix","year":"2024"},{"key":"10.1016\/j.josat.2026.210114_bb0195","series-title":"Raising the level of care for Paterson residents struggling with","author":"RealFix","year":"2025"},{"key":"10.1016\/j.josat.2026.210114_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108083","article-title":"Buprenorphine prescription dispensing rates and characteristics following federal changes in prescribing policy, 2017\u20132018: A cross-sectional study","volume":"213","author":"Roehler","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.josat.2026.210114_bb0205","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/1475-6773.12270","article-title":"Why we should not be indifferent to specification choices for difference-in-differences","volume":"50","author":"Ryan","year":"2015","journal-title":"Health Services Research"},{"key":"10.1016\/j.josat.2026.210114_bb0210","series-title":"Key substance use and mental health indicators in the United States: Results from the 2024 National Survey on Drug Use and Health","author":"SAMHSA","year":"2025"},{"issue":"1","key":"10.1016\/j.josat.2026.210114_bb0215","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.amepre.2023.01.037","article-title":"Buprenorphine after nonfatal opioid overdose: Reduced mortality risk in Medicare disability beneficiaries","volume":"65","author":"Samples","year":"2023","journal-title":"American Journal of Preventive Medicine"},{"issue":"5","key":"10.1016\/j.josat.2026.210114_bb0220","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1377\/hlthaff.2019.01085","article-title":"Impact of long-term buprenorphine treatment on adverse health care outcomes in Medicaid","volume":"39","author":"Samples","year":"2020","journal-title":"Health Affairs"},{"key":"10.1016\/j.josat.2026.210114_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2024.116660","article-title":"Barriers to opioid use disorder treatment among people who use drugs in the rural United States: A qualitative, multi-site study","volume":"346","author":"Stopka","year":"2024","journal-title":"Social Science & Medicine"},{"key":"10.1016\/j.josat.2026.210114_bb0230","series-title":"Fentanyl continues to be the leading cause of overdose deaths. What\u2019s being done to combat trafficking into the United States?","author":"U. S. Government Accountability Office","year":"2025"},{"key":"10.1016\/j.josat.2026.210114_bb0235","author":"US Census Bureau"},{"issue":"22","key":"10.1016\/j.josat.2026.210114_bb0240","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies\u2014Tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.josat.2026.210114_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108272","article-title":"Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic","volume":"124","author":"Wang","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2026.210114_bb0250","series-title":"AG report: Social media is a major vessel for the illicit distribution of fentanyl","author":"Wimbley","year":"2023"},{"issue":"1","key":"10.1016\/j.josat.2026.210114_bb0255","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13722-024-00516-z","article-title":"Strategies for improving treatment retention for buprenorphine\/naloxone for opioid use disorder: A qualitative study of issues and recommendations from prescribers","volume":"19","author":"Young","year":"2024","journal-title":"Addiction Science & Clinical Practice"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926002341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926002341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:28:03Z","timestamp":1791653283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875926002341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":50,"alternative-id":["S2949875926002341"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2026.210114","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased buprenorphine prescribing following implementation of a low-barrier virtual prescriber network","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2026.210114","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"210114"}}